Biofrontera Inc. to Report Third Quarter Financial Results on November 30, 2021

Rhea-AI Summary

Biofrontera Inc. (Nasdaq: BFRI) will announce its financial results for the three and nine months ending September 30, 2021, before the U.S. markets open on November 30, 2021. The company will host a conference call that day at 4:30 p.m. Eastern time to discuss the results and provide a business update. Biofrontera specializes in dermatological products and focuses on treating conditions such as actinic keratoses and impetigo. Investors can access the live webcast and replay on their website.

Positive

• Upcoming announcement of Q3 2021 financial results may provide investors with insight into company performance.
• Focus on specialized dermatological treatments could indicate a niche market advantage.

Negative

• None.

WOBURN, Mass., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, will report financial results for the three and nine months ended September 30, 2021 before the opening of the U.S. financial markets on Tuesday, November 30, 2021 and will hold a conference call that same day beginning at 4:30 p.m. Eastern time to discuss those results and provide a business update.

Conference Call and Webcast Information

What:	Biofrontera Inc. third quarter 2021 financial results and business update conference call
Date:	Tuesday, November 30, 2021
Time:	4:30 p.m. Eastern time
Conference Call:	1-866-524-3160 (toll free)
	1-412-317-6760 (international)
Webcast:	Live and 90-day replay webcast are available at https://investors.biofrontera-us.com/

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.

Contacts

Biofrontera Inc.
Pamela Keck
+1 781 486 1539
us-ir@biofrontera.com

LHA Investor Relations
Tirth T. Patel
+1 212 201 6614
tpatel@lhai.com

# # #

FAQ

When will Biofrontera report its Q3 2021 financial results?

Biofrontera will report its Q3 2021 financial results on November 30, 2021.

What time is the Biofrontera conference call for Q3 2021 results?

The conference call for Biofrontera's Q3 2021 results will be held at 4:30 p.m. Eastern time on November 30, 2021.

How can I access the Biofrontera conference call?

You can access the Biofrontera conference call by calling 1-866-524-3160 (toll free) or 1-412-317-6760 (international).

What products does Biofrontera specialize in?

Biofrontera specializes in dermatological products, particularly for treating actinic keratoses and bacterial skin infections like impetigo.